
Experts from the University of Arkansas Medical Sciences starts clinical trial of a vaccine to prevent recurrence of breast cancer.
According to Laura Hutchins, director of hematology and oncology, who was also the leader of the research, if successful, this vaccine is not to traditional treatments such as chemotherapy and radiation therapy to replace, but are used as additional treatment for patients.
Thomas Kieber-Emmons has been developed, director of basic research of breast cancer in the UAMS Winthrop P. Rockefeller Cancer Institute, said the vaccine under study, more than a decade studying the immune system. He said the most important...